New Investment: Xandar Kardian

We are excited to announce that Xandar Kardian, a trailblazer in health technology, has been welcomed into the ParticleX family as our latest investment.

Headquartered in Canada and operating in the US and South Korea, Xandar Kardian brings to the table an innovative healthcare portfolio, including a radar-based vital signs monitoring sensor and a people counter, both of which are pushing the boundaries of technological advancement.

The passion for continuous research and improvement demonstrated by Xandar Kardian has led to their recognition as finalists for the 2023 McKnight’s Tech Awards, Three 2023 CES Innovation Awards and 10 Top Innovative Medical Device 2022 by Fast Company and  TIME Magazine’s Best Inventions in 2022 list.

We look forward to supporting their mission to revolutionise health technology and eagerly anticipate the groundbreaking innovations they are set to introduce to the world.

For further information about Xandar Kardian and our other portfolio companies, please visit here.

A warm welcome is extended to Xandar Kardian into the ParticleX family!